US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 74.860
  • -0.080-0.11%
Close Jul 19 16:00 ET
  • 73.410
  • -1.450-1.94%
Post 17:12 ET
7.90BMarket Cap-64534P/E (TTM)

Intra-Cellular Therapies Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
52.90%144.84M
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
204.91%249.13M
242.66%87.43M
232.64%71.87M
189.76%55.07M
Operating revenue
52.90%144.84M
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
204.91%249.13M
242.66%87.43M
232.64%71.87M
189.76%55.07M
Cost of revenue
46.64%9.9M
65.07%33.75M
57.66%10.7M
56.05%9.13M
54.04%7.16M
113.98%6.75M
154.42%20.44M
167.35%6.79M
192.35%5.85M
127.94%4.65M
Gross profit
53.38%134.94M
87.34%428.43M
49.80%120.8M
76.74%116.68M
104.20%102.97M
178.42%87.98M
210.41%228.69M
250.98%80.65M
236.75%66.02M
197.19%50.42M
Operating expense
14.32%155.9M
19.40%587.81M
20.96%154.9M
20.34%146.39M
8.53%150.14M
30.80%136.37M
37.00%492.32M
17.50%128.06M
25.50%121.65M
60.67%138.35M
Selling and administrative expenses
14.32%113.09M
14.24%409.86M
10.66%104.72M
19.05%105.21M
0.70%101.01M
31.09%98.92M
31.61%358.78M
18.77%94.63M
25.36%88.38M
43.61%100.32M
Research and development costs
12.65%42.83M
33.72%180.14M
49.94%50.77M
24.87%41.55M
29.21%49.79M
30.92%38.02M
51.63%134.72M
14.95%33.86M
23.09%33.27M
122.79%38.54M
Other operating expenses
96.00%-23K
-85.70%-2.2M
-36.01%-593K
---363K
-31.49%-664K
-138.59%-575K
43.58%-1.18M
-181.29%-436K
----
51.44%-505K
Operating profit
56.70%-20.95M
39.54%-159.38M
28.08%-34.1M
46.59%-29.71M
46.34%-47.18M
33.40%-48.39M
7.72%-263.63M
44.87%-47.41M
28.06%-55.63M
-27.16%-87.92M
Net non-operating interest income expense
39.43%6.06M
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
370.41%7.38M
1,154.07%3.39M
439.95%2.12M
213.54%1.32M
Non-operating interest income
39.43%6.06M
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
370.41%7.38M
1,154.07%3.39M
439.95%2.12M
213.54%1.32M
Other net income (expense)
Income before tax
66.20%-14.89M
45.74%-139.04M
36.10%-28.13M
54.74%-24.22M
50.75%-42.65M
38.93%-44.04M
9.81%-256.25M
48.65%-44.03M
30.45%-53.51M
-26.02%-86.6M
Income tax
3,490.00%359K
10,500.00%636K
448K
4,200.00%43K
135K
100.00%10K
0.00%6K
0
104.35%1K
0
Net income
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
-25.98%-86.6M
Net income continuous Operations
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
-25.98%-86.6M
Minority interest income
Net income attributable to the parent company
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
-25.98%-86.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
30.43%-53.51M
-25.98%-86.6M
Basic earnings per share
65.22%-0.16
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
22.29%-2.72
57.14%-0.45
40.00%-0.57
-8.24%-0.92
Diluted earnings per share
65.22%-0.16
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
22.29%-2.72
57.14%-0.45
40.00%-0.57
-8.24%-0.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 52.90%144.84M85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M204.91%249.13M242.66%87.43M232.64%71.87M189.76%55.07M
Operating revenue 52.90%144.84M85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M204.91%249.13M242.66%87.43M232.64%71.87M189.76%55.07M
Cost of revenue 46.64%9.9M65.07%33.75M57.66%10.7M56.05%9.13M54.04%7.16M113.98%6.75M154.42%20.44M167.35%6.79M192.35%5.85M127.94%4.65M
Gross profit 53.38%134.94M87.34%428.43M49.80%120.8M76.74%116.68M104.20%102.97M178.42%87.98M210.41%228.69M250.98%80.65M236.75%66.02M197.19%50.42M
Operating expense 14.32%155.9M19.40%587.81M20.96%154.9M20.34%146.39M8.53%150.14M30.80%136.37M37.00%492.32M17.50%128.06M25.50%121.65M60.67%138.35M
Selling and administrative expenses 14.32%113.09M14.24%409.86M10.66%104.72M19.05%105.21M0.70%101.01M31.09%98.92M31.61%358.78M18.77%94.63M25.36%88.38M43.61%100.32M
Research and development costs 12.65%42.83M33.72%180.14M49.94%50.77M24.87%41.55M29.21%49.79M30.92%38.02M51.63%134.72M14.95%33.86M23.09%33.27M122.79%38.54M
Other operating expenses 96.00%-23K-85.70%-2.2M-36.01%-593K---363K-31.49%-664K-138.59%-575K43.58%-1.18M-181.29%-436K----51.44%-505K
Operating profit 56.70%-20.95M39.54%-159.38M28.08%-34.1M46.59%-29.71M46.34%-47.18M33.40%-48.39M7.72%-263.63M44.87%-47.41M28.06%-55.63M-27.16%-87.92M
Net non-operating interest income expense 39.43%6.06M175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M370.41%7.38M1,154.07%3.39M439.95%2.12M213.54%1.32M
Non-operating interest income 39.43%6.06M175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M370.41%7.38M1,154.07%3.39M439.95%2.12M213.54%1.32M
Other net income (expense)
Income before tax 66.20%-14.89M45.74%-139.04M36.10%-28.13M54.74%-24.22M50.75%-42.65M38.93%-44.04M9.81%-256.25M48.65%-44.03M30.45%-53.51M-26.02%-86.6M
Income tax 3,490.00%359K10,500.00%636K448K4,200.00%43K135K100.00%10K0.00%6K0104.35%1K0
Net income 65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M-25.98%-86.6M
Net income continuous Operations 65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M-25.98%-86.6M
Minority interest income
Net income attributable to the parent company 65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M-25.98%-86.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M30.43%-53.51M-25.98%-86.6M
Basic earnings per share 65.22%-0.1646.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.4622.29%-2.7257.14%-0.4540.00%-0.57-8.24%-0.92
Diluted earnings per share 65.22%-0.1646.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.4622.29%-2.7257.14%-0.4540.00%-0.57-8.24%-0.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg